Action results improve quality and ROI

A Smarttech Consulting Services product story

Edited by the Manufacturingtalk editorial team May 24, 2005

Smarttech Consulting Services has released the Smarttechcs Step Process which will provide businesses with a consultative formula to create business improvements, enabling regulatory compliance.

Smarttech Consulting Services, a leading provider of consultancy within the Pharmaceutical Industry has released the Smarttechcs Step Process which will provide businesses with a consultative formula to create business improvements utilising technology for enabling regulatory compliance.

"Companies that operate in regulated environments such as MHRA, FDA, US SEC or ISO are looking for a better business return when investing in technology.

We have the experience help within our services for regulated industries.

said Adrian Carter, Director for Smarttechcs.

"We have adopted a flexible methodology, Smarttechcs Step Process, which is based on investigation and understanding our clients' needs and action orientated results aimed towards the implementation of the business benefits identified.

Using on site team workshops, one on one consultation, or remote multimedia training for Life Science Business Managers, end users and suppliers to the regulated industries, Smarttechcs can extract specific advantages to their business aims.

"Companies should be able to deploy a regulatory remediation solution within their existing Process or Laboratory environment without excessive costs.

As compliance regulations become standardised worldwide, more companies are looking for assistance to provide a measurable business return for their investment" said Trevor Swift, Director for Smarttechcs.

"We are able to use our experience in helping businesses in the use of technology to aid Project Management, Electronic Document Management (eDMS), Corrective actions and Preventive actions (CAPA) systems, Electronic Laboratory Note Books (ELN) or Laboratory Information Management Systems (LIMS) and Instrument Interfacing, when used for regulatory compliance such as FDA 21 CFR part11 and Section 404 of the Sarbanes-Oxley Act (SOX404).